Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1321-01
Published May 29, 2013 · Recall initiated: April 1, 2013
Summary
FDA records drug Class II recall D-432-2013, published May 29, 2013 and initiated April 1, 2013. Recalling firm: Lloyd Inc. of Iowa; Status: Terminated; Reported quantity: 4,440 Bottles; Lot: Lot #: 1098751, Exp. Mar-13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lloyd Inc. of Iowa
- Distributor
- The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.
- Lot
- Lot #: 1098751, Exp. Mar-13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging,May 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDALevothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured forMay 29, 2013
- FDALevoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) andMay 29, 2013
- FDALevoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) andMay 29, 2013
Questions about this recall
Was Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1321-01 recalled?
Yes. FDA published recall D-432-2013 on May 29, 2013. Reported hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
What should I do if I have this product?
Voluntary: Firm initiated · Letter